Similarly, transmembrane GPC-1 promotes proliferation and metastatic growth of pancreatic cancer cells (103, 104), whereas, soluble GPC-1, inhibits the mitogenic response to FGF-2 and heparin-binding EGF-like growth factor (HBEGF) (104). This evidence concerns the gene GPC1 and pancreatic neoplasm.